Tricode AR and Vaqta Pediatric

• Generic Name: chlorpheniramine / codeine / pseudoephedrine
• Dosage Forms: n.a.
• Other Brand Names: Phenylhistine DH Expectorant, Tricode AR, Novahistine DH, Phenylhistine DH, Dihistine DH, Decohistine DH, Codehist DH, Novadyne DH, Co-Histine DH, Ryna-C, Codahistine-DH Elixir, Zodryl DAC

Chlorpheniramine is an antihistamine that reduces the effects of natural chemical histamine in the body. Histamine can produce symptoms of sneezing, itching, watery eyes, and runny nose.

Codeine is a narcotic cough suppressant. It affects the signals in the brain that trigger cough reflex.

Pseudoephedrine is a decongestant that shrinks blood vessels in the nasal passages. Dilated blood vessels can cause nasal congestion (stuffy nose).

Tricode AR is a combination medicine used to treat runny or stuffy nose, sneezing, itching, watery eyes, cough, and sinus congestion caused by allergies, the common cold, or the flu.

Tricode AR will not treat a cough that is caused by smoking, asthma, or emphysema.

Tricode AR may also be used for purposes not listed in this medication guide.

• Generic Name: hepatitis a pediatric vaccine
• Dosage Forms: n.a.
• Other Brand Names: Havrix Pediatric, Vaqta Pediatric

Hepatitis is a serious disease caused by a virus. Hepatitis causes inflammation of the liver, vomiting, and jaundice (yellowing of the skin or eyes). Hepatitis can lead to liver cancer, cirrhosis, or death.

Hepatitis A is spread through contact with the stool (bowel movements) of a person infected with the hepatitis A virus. This usually occurs by eating food or drinking water that has become contaminated as a result of handling by an infected person.

The Vaqta Pediatric is used to help prevent this disease in children.

This vaccine works by exposing your child to a small amount of the virus, which causes the body to develop immunity to the disease. This vaccine will not treat an active infection that has already developed in the body.

Vaccination with Vaqta Pediatric is recommended for all children who are 12 months of age or older. This vaccine is also recommended in children who travel to certain areas of the world where hepatitis A is a common disease.

Other risk factors for hepatitis in children include: receiving treatment for hemophilia or other bleeding disorders, or being in an area where there has been an outbreak of hepatitis A.

Like any vaccine, the Vaqta Pediatric may not provide protection from disease in every person.